Pak intensifies crackdown against militants, seizes religious schools

Agencies
March 7, 2019

Islamabad, Mar 7: Pakistan intensified its crackdown against so called Islamist militants on Thursday, with the government announcing it had taken control of 182 religious schools and detained more than 100 people as part of its push against banned groups.

The move represents Pakistan's biggest move against banned organisations in years and appears to be targeting Islamic welfare organisations that the United States says are a front for militant activities.

Pakistan is facing pressure from global powers to act against groups carrying out attacks in India, including Jaish-e-Mohammed (JeM), which claimed responsibility for the Feb. 14 attack that killed at least 40 Indian paramilitary police.

The escalating tension in the wake of the bombing led to a major confrontation between the nuclear-armed rivals, with both countries carrying out aerial bombing missions and even engaging in a brief dogfight that prompted fears of a war.

Pakistani officials say the crackdown is part of a long-planned drive and not a response to Indian anger over what New Delhi calls Islamabad's failure to rein in militant groups operating on Pakistani soil.

Previous large-scale crackdowns against anti-India militants have broadly been cosmetic, with the proscribed groups able to survive and continue operations.

The interior ministry said law enforcement agencies had placed 121 people in "preventive detention" as part of the crackdown that began this week.

"Provincial governments have taken in their control management and administration of 182 seminaries (madaris)", the ministry said in a statement, referring to religious schools.

What to do with madrasas is a thorny issue in Pakistan, a deeply conservative Muslim nation where religious schools are often blamed for the radicalisation of youngsters but are the only education available to millions of poor children.

The interior ministry said other institutions from different groups had been taken over, including 34 schools or colleges, 163 dispensaries, 184 ambulances, five hospitals and eight offices of banned organisations.

Many banned groups such as JeM run seminaries, which counter-terrorism officials say are used as recruiting grounds for militant outfits

Jamaat-ud-Dawa (JuD), which operates hospitals and a fleet of ambulances, is estimated to run about 300 madrasas across the country. Pakistan's government banned the group this week.

JuD calls itself a humanitarian charity but the U.S. State Department has designated it a "foreign terrorist organisation" and calls it a front for Lashkar-e-Taiba (LET), a Pakistan-based group accused of orchestrating attacks in India, including the 2008 Mumbai attack that killed 166 people.

JuD called the crackdown unfair and said it would seek to counter the government action in courts.

"The whole nation is asking that what message the government wants to send by sealing welfare organisations and kicking students out," said JuD spokesman Yahya Mujahid.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
May 15,2020

May 15: Global deaths linked to the novel coronavirus passed 300,000 on Thursday, while reported cases of the virus are approaching 4.5 million, according to a news agency tally.

About half of the fatalities have been reported by the United States, the United Kingdom and Italy.

The first death linked to the disease was reported on January 10 in Wuhan, China. It took 91 days for the death toll to pass 100,000 and a further 16 days to reach 200,000, according to the Reuters tally of official reports from governments. It took 19 days to go from 200,000 to 300,000 deaths.

By comparison, an estimated 400,000 people die annually from malaria, one of the world’s most deadly infectious diseases.

The United States had reported more than 85,000 deaths from the new coronavirus, while the United Kingdom and Italy have reported over 30,000 fatalities each.

While the current trajectory of COVID-19 falls far short of the 1918 Spanish flu, which infected an estimated 500 million people, killing at least 10% of patients, public health experts worry the available data is underplaying the true impact of the pandemic.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
Agencies
July 29,2020

If everything goes as Russia’s expectation, it will be world’s first country to approve a coronavirus vaccine for widespread in the second week of August despite safety and efficacy concerns, according to a report. The adenoviral vector-based vaccine developed by Russian military and government researchers is currently in phase 2 trials.

According to a report from CNN, Russian officials are hoping to get approval for the COVID-19 vaccine developed by the Moscow-based Gamaleya Institute on Agust 10 or even before that. The officials told the outlet that the vaccine will be approved for public use with frontline healthcare workers receiving it first.

“It’s a Sputnik moment,” said Kirill Dmitriev, head of Russia’s sovereign wealth fund, which is financing Russian vaccine research, referring to the successful 1957 launch of the world’s first satellite by the Soviet Union, according to CNN.

“Americans were surprised when they heard Sputnik’s beeping. It’s the same with this vaccine. Russia will have got there first,” he was quoted as saying.

However, Russia is yet to release the scientific data on its coronavirus vaccine trials, hence, questions remain about the safety and efficacy of the vaccine, said the report. The vaccine is in the second phase of testing with developers planning to launch the phase 3 trials sometime after August 3.

Earlier, Interfax reported, citing Health Minister Mikhail Murashko, that the vaccine will be widely used in parallel with phase 3 trials. He said the country plans to vaccinate medics who are at high-risk for COVID-19 next month before clinical trials are completed.

Murashko added that individuals at higher risk of getting infected with the coronavirus such as older people or those with health conditions will also be prioritised for the vaccine, although he did not estimate or reveal when that would happen. The minister added 800 people will be recruited for the phase 3 trials.

Meanwhile, health officials were more cautious considering the fact that human testing of the vaccine is incomplete, and the state registration is expected to begin after August 3, reported The Moscow Times.

On Monday, Moderna and Pfizer announced the commencement of the final phase 3 trials of their candidate vaccines against the SARS-CoV-2 virus, which has so far claimed at least 654,477 lives and infected 16,514,500 people worldwide. 

Researchers will recruit up to 30,000 volunteers in separate trials both backed by the US government. India's first indigenous coronavirus vaccine, COVAXIN, is undergoing phase 1 human clinical trials across the country. More than 150 COVID-19 vaccines are being developed all over the world with at least six candidates already in late-stage clinical trials.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.